770 - CLINDAMYCIN P04 1% TOP SWAB (770-25-3-801-0368)
ID: 36C77025Q0155Type: Solicitation
AwardedJun 25, 2025
$26.9K$26,928
AwardeeTHE JANZ CORP Columbus OH 43213 USA
Award #:36C77025P0188
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the procurement of Clindamycin PO4 1% Top Swabs, specifically for use in its Consolidated Mail Outpatient Pharmacy (CMOP) facilities. Vendors are required to submit a detailed pricing schedule, confirm compliance with safety and labeling standards, and adhere to strict delivery protocols, including providing necessary documentation such as state licenses and bar code compliance. This procurement is crucial for ensuring the availability of quality pharmaceutical supplies for veterans, reflecting the VA's commitment to regulatory compliance and operational efficiency. Interested vendors must submit their proposals by April 30, 2025, and can contact Jennifer L. Knight at jennifer.knight@va.gov or 913-684-0162 for further information.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Veterans Affairs (VA) is releasing a Presolicitation Notice for the procurement of Clindamycin P04 1% Top Swab. This requirement is aimed at multiple CMOP locations and is part of the VA Network Contracting Office 15. The items specified include various quantities for different locations, with an estimated issue date of April 23, 2025, and a response deadline of April 30, 2025. The solicitation is categorized as a Small Business Set-Aside, and bidders must provide a state wholesale distributor licensure, along with several other documentation requirements such as a signed SF1449 cover page and a Buy American Act Certificate. All submissions are to be directed to Contract Specialist Jennifer Knight via email. Compliance with the Drug Supply Chain Security Act is emphasized for vendor qualifications, ensuring that all responsible parties are informed about the necessary regulatory requirements for their proposals. This notice outlines the fundamental aspects of the procurement process relevant to potential offerors, guiding them on how to respond effectively while adhering to federal procurement protocols.
    The document outlines a Request for Quotation (RFQ) related to the procurement of pharmaceutical supplies for the Veterans Affairs (VA) CMOP facilities. The RFQ (36C77025Q0155) was posted on April 23, 2025, with a closing date of April 30, 2025, at 4:00 PM Central Time. Vendors are required to submit a completed SF1449 form, a detailed quote in an Excel spreadsheet that specifies the place of manufacture, and a valid state wholesale distributor license along with a Buy American Act (BAA) Certificate while complying with specified expiration requirements for the supplies. The RFQ includes sections for various line items detailing the purchase of “60 Pledgets” jars across multiple VA CMOP sites, highlighting quantities and leaving fields for unit prices and total prices. The document emphasizes adherence to the Buy American Act and lists specific product details using National Drug Codes (NDCs). It aims to ensure procurement meets VA standards and guidelines, ensuring the availability of necessary medical supplies for veterans. This RFQ exemplifies the federal government's structured approach to acquiring medical supplies through a transparent bidding process.
    The document outlines a solicitation by the Department of Veterans Affairs (VA) for pharmaceutical products, specifically focusing on Clindamycin PO4 1% Top Swabs, for the Consolidated Mail Outpatient Pharmacy (CMOP) across multiple locations. The requisition number is 36C77025Q0155, with a proposal submission deadline of April 30, 2025. Key requirements include the submission of a detailed pricing schedule in Excel format, confirmation of product compliance with safety and labeling standards, and adherence to strict delivery protocols. Vendors are expected to provide additional documentation, such as state licenses and bar code compliance for all pharmaceutical products. The contractor must ensure product availability and communicate shipment details to designated VA contacts. The document also establishes contract terms and clauses, particularly regarding acceptance of goods, invoice processing, and compliance with the Drug Supply Chain Security Act. Emphasis is placed on the need for submitted quotations to be complete, or they will be deemed non-compliant. This solicitation thus reflects the VA’s commitment to acquiring quality pharmaceutical supplies while ensuring regulatory compliance and operational efficiency.
    Similar Opportunities
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM - 762 TUCSON
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify potential qualified domestic sources for the procurement of COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM through its National CMOP Office. This announcement serves as a market research tool rather than a solicitation, aiming to gather information on vendors' capabilities to meet the requirements outlined in the Statement of Requirements. The products sought are critical for pharmaceutical preparation and will support the healthcare needs of veterans. Interested vendors must submit their responses, including company details and capability statements, via email to Jennifer Coleman at Jennifer.Coleman4@va.gov by December 19, 2025, at 3:00 PM CDT. This notice does not obligate the VA to issue a solicitation.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for operational and mailing supplies to support seven Consolidated Mail Outpatient Pharmacy (CMOP) locations across the United States. The procurement includes a wide range of items such as resealable bags, corrugated boxes, various types of mailers, child-resistant medical pouches, and packaging materials, all of which must adhere to specific material and postal regulations. This contract is crucial for ensuring the efficient operation of CMOP facilities, which play a vital role in delivering medications to veterans. Interested parties should contact Kelly L Mann at kelly.mann@va.gov or Larry Zaritz at larry.zaritz@va.gov for further details, and must review the attached documents, including the pricing schedule and past performance requirements, as submissions are due by the specified deadlines.
    VA Direct to Patient supply services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to provide direct delivery supply services for medical and surgical items to Veteran patients through its Consolidated Mail Outpatient Pharmacy (CMOP) program. The contractor must demonstrate at least two years of experience, the capacity to process approximately 14 million prescriptions annually, and the ability to maintain compliance with federal and state regulations while ensuring a 48-hour average turnaround time for prescription fulfillment. This opportunity is critical for ensuring timely access to essential medical supplies for Veterans, with the contract structured to reimburse vendors per filled prescription at government contract prices, plus handling fees. Interested vendors must submit a capabilities statement to the primary contact, Phillip Reuwer, at Phillip.Reuwer@va.gov by January 11, 2026, with any questions directed to the same contact before January 8, 2026.
    6505--LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB (VA-26-00008212)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to supply LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB, as part of solicitation number 36C77026Q0005. This procurement involves delivering a total of 1,460 boxes of the pharmaceutical product to the VA CMOP facility in Hines, Illinois, with a base period and four option years, each requiring delivery by January 5th of the respective year. The goods are critical for patient care within the VA healthcare system, emphasizing the importance of timely and compliant delivery. Interested vendors must submit their proposals, including a signed SF 1449, pricing schedule, and other required documentation, by December 16, 2025, at 3 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    R499--Sterile Compounding Compliance QA Program
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through the Network Contracting Office 17, is seeking proposals for a Sterile Compounding Compliance Quality Assurance Program, specifically set aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSB). This program encompasses a range of services, including monthly garbing competency assessments, media fill tests, hazardous drug manipulation competency evaluations, and cleaning and disinfection competency checks, with a contract period extending from January 1, 2026, to December 31, 2030. The importance of this procurement lies in ensuring compliance and safety in sterile compounding practices, which are critical for patient care in healthcare settings. Interested parties must submit their proposals by December 5, 2025, at 12 PM CST, and can direct inquiries to Contracting Specialist Matt Lee at matthew.lee5@va.gov or by phone at 210-393-9281.
    Tucson CMOP COAL TAR 2% SHAMPOO 240ML AND MOISTURIZING LOTION
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting a Sources Sought Notice for domestically manufactured pharmaceuticals, specifically COAL TAR 2% SHAMPOO and MOISTURIZING LOTION, for its Consolidated Mail Outpatient Pharmacy (CMOP) program in Tucson, Arizona. This market research effort aims to identify qualified small and large business manufacturers or distributors capable of supplying these products, which are essential for treating various dermatological conditions. Interested parties must respond by December 15, 2025, at 16:00 CDT, providing necessary company information and ensuring registration in SAM, with inquiries directed to Sarah Fry at sarah.fry2@va.gov or by phone at 913-758-9935. This notice does not guarantee a contract award but facilitates early information exchange.